171 related articles for article (PubMed ID: 22211332)
1. An atypical melanocytic lesion without genomic abnormalities shows locoregional metastasis.
Abraham RM; Ming ME; Elder DE; Xu X
J Cutan Pathol; 2012 Jan; 39(1):21-4. PubMed ID: 22211332
[TBL] [Abstract][Full Text] [Related]
2. Deep penetrating nevus-like borderline tumors: A unique subset of ambiguous melanocytic tumors with malignant potential and normal cytogenetics.
Magro CM; Abraham RM; Guo R; Li S; Wang X; Proper S; Crowson AN; Mihm M
Eur J Dermatol; 2014; 24(5):594-602. PubMed ID: 25118781
[TBL] [Abstract][Full Text] [Related]
3. Histologically ambiguous ("borderline") primary cutaneous melanocytic tumors: approaches to patient management including the roles of molecular testing and sentinel lymph node biopsy.
Scolyer RA; Murali R; McCarthy SW; Thompson JF
Arch Pathol Lab Med; 2010 Dec; 134(12):1770-7. PubMed ID: 21128774
[TBL] [Abstract][Full Text] [Related]
4. Melanocytic tumors of uncertain malignant potential: results of a tutorial held at the XXIX Symposium of the International Society of Dermatopathology in Graz, October 2008.
Cerroni L; Barnhill R; Elder D; Gottlieb G; Heenan P; Kutzner H; LeBoit PE; Mihm M; Rosai J; Kerl H
Am J Surg Pathol; 2010 Mar; 34(3):314-26. PubMed ID: 20118771
[TBL] [Abstract][Full Text] [Related]
5. Correlating array comparative genomic hybridization findings with histology and outcome in spitzoid melanocytic neoplasms.
Ali L; Helm T; Cheney R; Conroy J; Sait S; Guitart J; Gerami P
Int J Clin Exp Pathol; 2010 Jun; 3(6):593-9. PubMed ID: 20661407
[TBL] [Abstract][Full Text] [Related]
6. Copy number variations and clinical outcome in atypical spitz tumors.
Raskin L; Ludgate M; Iyer RK; Ackley TE; Bradford CR; Johnson TM; Fullen DR
Am J Surg Pathol; 2011 Feb; 35(2):243-52. PubMed ID: 21263245
[TBL] [Abstract][Full Text] [Related]
7. Giant lung metastasis of NRAS-mutant melanoma in a 24-year-old patient with a history of BRAF-mutant conventional melanoma harboring Spitzoid morphology: a case report.
Vachtenheim J; Kodet R; Fischer O; Kolek V; Strizova Z; Ozaniak A; Simonek J; Stolz A; Pozniak J; Kolarik J; Svorcova M; Vachtenheim J; Lischke R
Diagn Pathol; 2020 Oct; 15(1):132. PubMed ID: 33100226
[TBL] [Abstract][Full Text] [Related]
8. Role of In Vivo Reflectance Confocal Microscopy in the Analysis of Melanocytic Lesions.
Serban ED; Farnetani F; Pellacani G; Constantin MM
Acta Dermatovenerol Croat; 2018 Apr; 26(1):64-67. PubMed ID: 29782304
[TBL] [Abstract][Full Text] [Related]
9. Atypical Spitz Tumors: A Diagnostic Challenge.
Harms KL; Lowe L; Fullen DR; Harms PW
Arch Pathol Lab Med; 2015 Oct; 139(10):1263-70. PubMed ID: 26414472
[TBL] [Abstract][Full Text] [Related]
10. Clinical Features, Dermoscopic Patterns, and Histological Diagnostic Model for Melanocytic Tumors of Uncertain Malignant Potential (MELTUMP).
Pusiol T; Piscioli F; Speziali L; Zorzi MG; Morichetti D; Roncati L
Acta Dermatovenerol Croat; 2015; 23(3):185-94. PubMed ID: 26476902
[TBL] [Abstract][Full Text] [Related]
11. Understanding the progression of melanocytic neoplasia using genomic analysis: from fields to cancer.
Bastian BC
Oncogene; 2003 May; 22(20):3081-6. PubMed ID: 12789284
[TBL] [Abstract][Full Text] [Related]
12. Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy.
Wiesner T; Kutzner H; Cerroni L; Mihm MC; Busam KJ; Murali R
Pathology; 2016 Feb; 48(2):113-31. PubMed ID: 27020384
[TBL] [Abstract][Full Text] [Related]
13. Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions.
Zembowicz A; Knoepp SM; Bei T; Stergiopoulos S; Eng C; Mihm MC; Stratakis CA
Am J Surg Pathol; 2007 Nov; 31(11):1764-75. PubMed ID: 18059235
[TBL] [Abstract][Full Text] [Related]
14. A Diagnostic Algorithm Combining Immunohistochemistry and Molecular Cytogenetics to Diagnose Challenging Melanocytic Tumors.
Redon S; Guibourg B; Talagas M; Marcorelles P; Uguen A
Appl Immunohistochem Mol Morphol; 2018; 26(10):714-720. PubMed ID: 28362709
[TBL] [Abstract][Full Text] [Related]
15. Persistent (recurrent) Spitz nevi: a histopathologic, immunohistochemical, and molecular pathologic study of 22 cases.
Harvell JD; Bastian BC; LeBoit PE
Am J Surg Pathol; 2002 May; 26(5):654-61. PubMed ID: 11979096
[TBL] [Abstract][Full Text] [Related]
16. miR-21 and miR-155 are associated with mitotic activity and lesion depth of borderline melanocytic lesions.
Grignol V; Fairchild ET; Zimmerer JM; Lesinski GB; Walker MJ; Magro CM; Kacher JE; Karpa VI; Clark J; Nuovo G; Lehman A; Volinia S; Agnese DM; Croce CM; Carson WE
Br J Cancer; 2011 Sep; 105(7):1023-9. PubMed ID: 21863027
[TBL] [Abstract][Full Text] [Related]
17. Two cases of unusual acral melanocytic tumors: illustration of molecular cytogenetics as a diagnostic tool.
Takata M; Maruo K; Kageshita T; Ikeda S; Ono T; Shirasaki F; Takehara K; Bastian BC
Hum Pathol; 2003 Jan; 34(1):89-92. PubMed ID: 12605371
[TBL] [Abstract][Full Text] [Related]
18. Sentinel lymph node biopsy in patients with diagnostically controversial spitzoid melanocytic tumors.
Lohmann CM; Coit DG; Brady MS; Berwick M; Busam KJ
Am J Surg Pathol; 2002 Jan; 26(1):47-55. PubMed ID: 11756768
[TBL] [Abstract][Full Text] [Related]
19. The dermal-based borderline melanocytic tumor: a categorical approach.
Magro CM; Crowson AN; Mihm MC; Gupta K; Walker MJ; Solomon G
J Am Acad Dermatol; 2010 Mar; 62(3):469-79. PubMed ID: 20159313
[TBL] [Abstract][Full Text] [Related]
20. PRAME expression in melanocytic proliferations with intermediate histopathologic or spitzoid features.
Raghavan SS; Wang JY; Kwok S; Rieger KE; Novoa RA; Brown RA
J Cutan Pathol; 2020 Dec; 47(12):1123-1131. PubMed ID: 32700786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]